Table 4.
Baseline CD4+ count in cells/μL, n (%) | |||
---|---|---|---|
200–349 | 350–499 | ≥500 | |
Twenty-four months after initiating ART (N = 24,274) | |||
Number of noninjury death | 658 (3%) | 124 (2%) | 54 (3%) |
Number of people on treatment | 20,827 | 4336 | 1589 |
Unadjusted HR (95% CI), p-value | 0.90 (0.68–1.19), 0.46 | 0.82 (0.59–1.13), 0.22 | 1 |
HR adjusted by all factorsa but not transmission mode (95% CI), p-value | 0.77 (0.58–1.01), 0.11 | 0.77 (0.56–1.06), 0.062 | 1 |
HR adjusted by all factorsa and transmission mode (95% CI), p-value | 0.97 (0.73–1.28), 0.82 | 0.86 (0.63–1.19), 0.36 | 1 |
All factors here include sex and age. Factors such as type of treatment center and initial ART regimen were not included in the analysis, because they were shown to be insignificant from our previous studies. Marital status was not included because it was shown to be insignificant in the univariate analysis.
ART, antiretroviral therapy; HR, hazard ratios.